Proteomics International Laboratories Ltd (PIQ) - Product Pipeline Analysis, 2026 Update
Description
Summary
Proteomics International Laboratories Ltd (Proteomics International) is a medical technology company specializing in predictive diagnostics and bio-analytical services. It offer promarker platform technology products such as Promarker D, Promarker ESO, Promarker ENDO, OxiDx, and Promarker Pipeline. The company carries out the study of proteomics, which involves the large-scale analysis of protein structures and functions. Proteomics International also offers technology for discovering diagnostic tests. The company offers services such as project consultation, biomarker services, and protein analysis, among others. It serves the drug business. Proteomics is headquartered in Perth, Western Australia, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Proteomics International Laboratories Ltd (Proteomics International) is a medical technology company specializing in predictive diagnostics and bio-analytical services. It offer promarker platform technology products such as Promarker D, Promarker ESO, Promarker ENDO, OxiDx, and Promarker Pipeline. The company carries out the study of proteomics, which involves the large-scale analysis of protein structures and functions. Proteomics International also offers technology for discovering diagnostic tests. The company offers services such as project consultation, biomarker services, and protein analysis, among others. It serves the drug business. Proteomics is headquartered in Perth, Western Australia, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Proteomics International Laboratories Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
42 Pages
- Proteomics International Laboratories Ltd Company Overview
- Proteomics International Laboratories Ltd Company Snapshot
- Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Proteomics International Laboratories Ltd – Pipeline Analysis Overview
- Proteomics International Laboratories Ltd - Key Facts
- Proteomics International Laboratories Ltd - Major Products and Services
- Proteomics International Laboratories Ltd Pipeline Products by Development Stage
- Proteomics International Laboratories Ltd Pipeline Products Overview
- Diagnostic Test - Alzheimer's Disease
- Diagnostic Test - Alzheimer's Disease Product Overview
- Next Generation Diagnostic Test
- Next Generation Diagnostic Test Product Overview
- Promarker Test - Asthma And COPD
- Promarker Test - Asthma And COPD Product Overview
- Promarker Test - COVID-19
- Promarker Test - COVID-19 Product Overview
- Promarker Test - COVID-19 Dx
- Promarker Test - COVID-19 Dx Product Overview
- Promarker Test - Diabetic Retinopathy
- Promarker Test - Diabetic Retinopathy Product Overview
- Promarker Test - Giardia
- Promarker Test - Giardia Product Overview
- Promarker Test - Mesothelioma
- Promarker Test - Mesothelioma Product Overview
- PromarkerD Companion Diagnostic Test
- PromarkerD Companion Diagnostic Test Product Overview
- PromarkerEndo
- PromarkerEndo Product Overview
- PromarkerEso
- PromarkerEso Product Overview
- Proteomics International Laboratories Ltd - Key Competitors
- Proteomics International Laboratories Ltd - Key Employees
- Proteomics International Laboratories Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Proteomics International Laboratories Ltd, Recent Developments
- Feb 05, 2026: Proteomics International Laboratories Announces Resignation of Joint Company Secretary
- Jan 16, 2026: Canadian Patent Secured for Promarkereso Diagnostic Test For Esophageal Adenocarcinoma
- Dec 16, 2025: Australian Clinical Utility Study Demonstrates Promarkerd Test Offers Improved Treatment Options for Doctors in the Fight Against Diabetic Kidney Disease
- Nov 26, 2025: US Medicare Sets Reimbursement Price for Next-Generation Promarker D Predictive Test for Diabetic Kidney Disease
- Nov 12, 2025: Proteomics International receives $2.2 million in R&D tax incentive
- Nov 06, 2025: Promarkerendo Diagnostic Test for Endometriosis Receives $0.5 Million Grant From WA Government to Support Commercialisation
- Sep 08, 2025: Promarkereso Blood Test Detects Early Stages of Esophageal Adenocarcinoma With High Accuracy
- Jul 24, 2025: Performance of Next-Generation PromarkerD Test System Published in The Journal of Applied Laboratory Medicine
- Jul 03, 2025: American Medical Association Grants Proteomics International's Next Generation PromarkerD test a dedicated CPT PLA Reimbursement Code
- Jul 01, 2025: WA Proteomics Facility Receives $6m Boost to Supercharge Precision Diagnostics
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
- Proteomics International Laboratories Ltd Pipeline Products by Indication
- Proteomics International Laboratories Ltd, Key Facts
- Proteomics International Laboratories Ltd, Major Products and Services
- Proteomics International Laboratories Ltd Number of Pipeline Products by Development Stage
- Proteomics International Laboratories Ltd Pipeline Products Summary by Development Stage
- Diagnostic Test - Alzheimer's Disease - Product Status
- Diagnostic Test - Alzheimer's Disease - Product Description
- Next Generation Diagnostic Test - Product Status
- Next Generation Diagnostic Test - Product Description
- Promarker Test - Asthma And COPD - Product Status
- Promarker Test - Asthma And COPD - Product Description
- Promarker Test - COVID-19 - Product Status
- Promarker Test - COVID-19 - Product Description
- Promarker Test - COVID-19 Dx - Product Status
- Promarker Test - COVID-19 Dx - Product Description
- Promarker Test - Diabetic Retinopathy - Product Status
- Promarker Test - Diabetic Retinopathy - Product Description
- Promarker Test - Giardia - Product Status
- Promarker Test - Giardia - Product Description
- Promarker Test - Mesothelioma - Product Status
- Promarker Test - Mesothelioma - Product Description
- PromarkerD Companion Diagnostic Test - Product Status
- PromarkerD Companion Diagnostic Test - Product Description
- PromarkerEndo - Product Status
- PromarkerEndo - Product Description
- PromarkerEso - Product Status
- PromarkerEso - Product Description
- Proteomics International Laboratories Ltd, Key Employees
- Proteomics International Laboratories Ltd, Other Locations
- Glossary
- List of Figures
- Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
- Proteomics International Laboratories Ltd Pipeline Products by Development Stage
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
